SOPHARMA

Research SOPHARMA (SPH.WA) on Bullrun: market cap PLN 5.22B, dividend yield 4.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is PLN 5.22B; dividend yield is 4.2%.

Peer valuation comparison

Latest dividend yield is 4.17% versus a Healthcare sector median of 2.1% (98.6% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-09-06PLN 5.22Bn/a4.3%0.41

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.41 PLN, yield 4.2%.

About SOPHARMA

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is SOPHARMA's market cap?

SOPHARMA's market capitalization is PLN 5.22B.

Does SOPHARMA pay a dividend?

SOPHARMA has a dividend yield of 4.2%.

What does SOPHARMA do?

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana, a herbal medicine to reduce the stress; veterinary vaccines; and medical devices, such as.